Medacta Group Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Medacta Group hat ein Gesamteigenkapital von €344.2M und eine Gesamtverschuldung von €186.3M, wodurch sich der Verschuldungsgrad auf 54.1% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen €731.9M bzw. €387.7M. Medacta Group Das EBIT des Unternehmens beträgt €78.3M, so dass der Zinsdeckungsgrad -42.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von €16.4M.
Wichtige Informationen
54.1%
Verhältnis von Schulden zu Eigenkapital
€186.29m
Verschuldung
| Zinsdeckungsgrad | -42.5x |
| Bargeld | €16.41m |
| Eigenkapital | €344.15m |
| Gesamtverbindlichkeiten | €387.71m |
| Gesamtvermögen | €731.87m |
Jüngste Berichte zur Finanzlage
Is Medacta Group (VTX:MOVE) A Risky Investment?
Oct 14
Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet
Apr 17Is Medacta Group (VTX:MOVE) Using Too Much Debt?
Sep 29Is Medacta Group (VTX:MOVE) A Risky Investment?
Apr 08Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?
Nov 09These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well
Mar 31Recent updates
The Price Is Right For Medacta Group SA (VTX:MOVE)
Nov 22Is Medacta Group (VTX:MOVE) A Risky Investment?
Oct 14Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate
Sep 06What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?
Aug 21Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
Aug 06Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable
Jun 20We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 01Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet
Apr 17Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Mar 29Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Feb 22Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around
Feb 07Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult
Dec 18Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Dec 04Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Nov 15Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)
Oct 30If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity
Oct 17Is Medacta Group (VTX:MOVE) Using Too Much Debt?
Sep 29Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Aug 11Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Jul 27Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital
Jul 03At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?
Apr 28Is Medacta Group (VTX:MOVE) A Risky Investment?
Apr 08Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Dec 25Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal
Dec 09Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?
Nov 09Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching
Sep 16The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence
Aug 20Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors
Jul 02Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?
May 28Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
May 12These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well
Mar 31Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Mar 17Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future
Feb 07Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?
Dec 10Medacta Group (VTX:MOVE) Knows How To Allocate Capital
Nov 05Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly
Sep 30Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?
Aug 26Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital
Jul 20Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?
May 19We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt
Apr 05What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition
Mar 02Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?
Feb 02The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More
Jan 12
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture
Dec 21Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?
Dec 03Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: MOVEDie kurzfristigen Aktiva des Unternehmens (€364.3M) übersteigen seine kurzfristigen Passiva (€165.8M).
Langfristige Verbindlichkeiten: MOVEDie kurzfristigen Vermögenswerte des Unternehmens (€364.3M) übersteigen seine langfristigen Verbindlichkeiten (€221.9M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: MOVEDie Nettoverschuldung im Verhältnis zum Eigenkapital (49.4%) wird als hoch angesehen.
Schulden abbauen: MOVE Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 141.1% auf 54.1% zurückgegangen.
Schuldendeckung: MOVEDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (42.7%).
Zinsdeckung: MOVE mehr Zinsen einnimmt als er zahlt, so dass die Deckung der Zinszahlungen kein Problem darstellt.